Medicus Pharma reports 80% response rate in skin cancer study

March 26, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ: MDCX) announced results from its Phase 2 SkinJect study showing an 80% overall response rate in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found